Cinhyaluronate sodium

N/A

Report date: 2024/01/02 20:03:52
NME

Base Information

Drug NameCinhyaluronate sodium
Drug Alias NameHyaluronic acid ophthalmicSI-614
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsDry Eye Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesSeikagaku
China Registration ClassN/A

Develop Information

Active CompaniesSeikagaku Co
Inactive CompaniesN/A
Active IndicationsDry Eye Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A